See more : Koninklijke Ahold Delhaize N.V. (AD.MI) Income Statement Analysis – Financial Results
Complete financial analysis of Mountain Valley MD Holdings Inc. (MVMDF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mountain Valley MD Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Cybernaut International Holdings Company Limited (1020.HK) Income Statement Analysis – Financial Results
- GeNeuro SA (GNRO.PA) Income Statement Analysis – Financial Results
- New Universe Environmental Group Limited (0436.HK) Income Statement Analysis – Financial Results
- Nickel Industries Limited (NIC.AX) Income Statement Analysis – Financial Results
- InterCloud Systems, Inc. (ICLD) Income Statement Analysis – Financial Results
Mountain Valley MD Holdings Inc. (MVMDF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.mountainvalleymd.com
About Mountain Valley MD Holdings Inc.
Mountain Valley MD Holdings Inc., through its subsidiary, Mountain Valley MD Inc., operates as a health and wellness company. The company engages in the implementation and licensing of its technologies to pharmaceutical, vaccine, and nutraceutical third parties. It offers Quicksome oral drug formulation and delivery technologies; Quicksol solubility formulation technology; and dose sparing adjuvant. In addition, the company is developing IM032 for the treatment of male beagle dogs for comparing intramuscular and subcutaneous dosing. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.00K | 0.00 | 110.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 406.00K | 446.00K | 40.00K | 430.19K | 52.16K | 0.00 | 39.70K | 48.02K | 48.00K |
| Gross Profit | -346.00K | -446.00K | 70.00K | -430.19K | -52.16K | 0.00 | -39.70K | -48.02K | -48.00K |
| Gross Profit Ratio | -576.67% | 0.00% | 63.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 70.00K | 1.47M | 1.18M | 1.36M | 52.16K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.57M | 3.63M | 3.55M | 3.37M | 2.45M | 1.79M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 200.00K | 0.00 | 0.00 | 0.00 | 570.83K | 317.47K | 0.00 | 0.00 | 0.00 |
| SG&A | 2.77M | 3.63M | 3.55M | 3.37M | 3.02M | 887.23K | 923.00K | 747.57K | 1.39M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 60.00K | 5.55M | 5.16M | 5.16M | 3.10M | 887.23K | 923.00K | 747.57K | 1.39M |
| Cost & Expenses | 3.25M | 5.55M | 5.16M | 5.16M | 3.15M | 887.23K | 962.70K | 795.59K | 1.43M |
| Interest Income | 274.00K | 267.00K | 5.00K | 5.00K | 2.03K | 0.00 | 889.00 | 227.00 | 1.80K |
| Interest Expense | 0.00 | 0.00 | 20.18K | 20.00K | 37.24K | 9.80K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 416.00K | 446.00K | 451.00K | 430.19K | 75.86K | 2.13M | 39.70K | 48.02K | 48.00K |
| EBITDA | -2.78M | -5.15M | -9.29M | -4.77M | -3.15M | 0.00 | -923.00K | -747.57K | -1.39M |
| EBITDA Ratio | -4,633.33% | 0.00% | -4,411.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.19M | -3.50M | -5.28M | -5.28M | -3.23M | -887.23K | -962.70K | -795.59K | -1.43M |
| Operating Income Ratio | -5,310.00% | 0.00% | -4,802.23% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -4.58M | -2.23M | -418.00K | -3.41M | -15.62M | -23.52K | 885.00 | 229.00 | 1.80K |
| Income Before Tax | -7.76M | -7.33M | -8.14M | -8.14M | -18.84M | -897.03K | -961.82K | -795.36K | -1.43M |
| Income Before Tax Ratio | -12,936.67% | 0.00% | -7,402.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -92.00K | 109.00K | -104.82K | -105.00K | -46.09K | -171.86K | 0.00 | 3.00 | 4.00 |
| Net Income | -7.67M | -7.44M | -8.14M | -8.14M | -18.84M | -897.03K | -961.82K | -795.36K | -1.43M |
| Net Income Ratio | -12,783.33% | 0.00% | -7,402.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.09 | -0.08 | -0.23 | -0.29 | -0.63 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.03 | -0.09 | -0.08 | -0.23 | -0.29 | -0.63 |
| Weighted Avg Shares Out | 329.67M | 329.65M | 329.24M | 263.51M | 208.41M | 11.72M | 4.20M | 2.78M | 2.28M |
| Weighted Avg Shares Out (Dil) | 329.65M | 329.65M | 329.24M | 263.51M | 208.41M | 11.72M | 4.20M | 2.78M | 2.28M |
Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024
TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Yong Yao to the role of Chief Financial Officer effective January 15, 2024. The Company has accepted...
Mountain Valley MD appoints Lucie Letellier as new CFO
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) announced it has appointed Lucie Letellier to replace Aaron Triplett as its chief financial officer effective September 11, 2023. Triplett will remain as a non-executive consultant with the company until November 30 to ensure...
Mountain Valley MD Announces Appointment of New CFO
TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Lucie Letellier to the role of Chief Financial Officer effective September 11, 2023. Ms. Letellier succeeds Aaron...
Mountain Valley MD highlights progress in core business lines
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it continues to progress in commercializing its three core lines of business. “The MVMD team and our extensive network of partners has been making significant progress on our commercialization objectives,” Dennis Hancock,...
Mountain Valley MD Provides Business Update
TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to provide a business update and details of its current progress. The Company has been working towards commercialization of its three core...
Mountain Valley MD Announces Publication of Soluvec™ Trial Data in Therapeutic Delivery
TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), a leading-edge publicly traded biotech company whose science includes that of novel solubilization methods for therapeutic compounds, is pleased to announce the recent peer-reviewed...
Mountain Valley MD licenses modified ivermectin product to treat fish and wildlife for parasites in Bangladesh
Mountain Valley MD has agreed to a license its parasitic infection treatment Soluvec 1% to a private Ontario company that intends to use it for animal husbandry applications in Bangladesh. The agreement allows the licensee to coordinate Soluvec 1% manufacturing...
Mountain Valley MD highlights shift to commercially focused biotech with revenue-generating activities in business update
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it has shifted focus to the commercialization strategy for those of its projects and technologies that it believes will best provide viable revenue streams for long-term company health and shareholder value. In...
Mountain Valley MD kicks off commercial sales of Agrarius, an agro plant technology
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it has begun commercial sales and marketing of Agrarius, a certified organic product designed to be applied to agricultural crops to naturally increase yields, reduce fertilizer use, and increase general resilience to pests...
Mountain Valley MD updates on its technologies and pre-clinical progress across broad husbandry animal and human applications
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) provided a sweeping update on how it is rapidly advancing its patented Quicksome oral drug formulation and Quicksol solubility formulation technologies through key initiatives. The Toronto-based company is building a world-class organization centered...
Source: https://incomestatements.info
Category: Stock Reports